Jianqin Lu has completed his PhD from University of Pittsburgh and postdoctoral studies from University of Chicago and University of California, Los Angeles.
He is the director of Pharmaceutics and Pharmacokinetics Track at The University of Arizona R. Ken Coit College of Pharmacy.
His research laboratory strives to develop innovative, safe, and efficacious therapeutics at the interface of drug delivery, synthetic chemistry, pharmaceutics, nanotechnology, and tumor immunology to address the pressing unmet needs in current cancer and other diseases therapy and prevention.
Biography:
Jianqin Lu
The University of Arizona
Jianqin Lu has completed his PhD from University of Pittsburgh and postdoctoral studies from University of Chicago and University of California, Los Angeles.
He is the director of Pharmaceutics and Pharmacokinetics Track at The University of Arizona R. Ken Coit College of Pharmacy.
His research laboratory strives to develop innovative, safe, and efficacious therapeutics at the interface of drug delivery, synthetic chemistry, pharmaceutics, nanotechnology, and tumor immunology to address the pressing unmet needs in current cancer and other diseases therapy and prevention.